Physician profile
Margaret A Kaiser
NPI 1396732129
$706.27
in general payments reported to CMS, 2019-2025
18 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.38 · 2022: $22.44 · 2023: $21.73 · 2024: $210 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.46 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $99.99 | 2025 | |
| Janssen Biotech, INC. | $90.01 | 2025 | Darzalex, Tecvayli, Talvey |
| Eisai INC. | $82.01 | 2019-2025 | |
| Celgene Corporation | $67.75 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.01 | 2024-2025 | Fruzaqla |
| Merck Sharp & Dohme LLC | $44.53 | 2022-2025 | Keytruda |
| Astrazeneca Pharmaceuticals Lp | $43.76 | 2025 | |
| Novartis Pharmaceuticals Corporation | $25.20 | 2025 | |
| Gilead Sciences, INC. | $23.34 | 2024 | |
| Astellas Pharma US INC | $21.73 | 2023 | Padcev |
| Axonics, INC. | $20.54 | 2024 | Bulkamid |
| Genentech USA, INC. | $19.31 | 2024 | Tecentriq Hybreza, Tecentriq, Alecensa |
| Beone Medicines USA, INC. | $19.20 | 2025 | Tevimbra |
| Acrotech Biopharma INC. | $18.52 | 2024 | Beleodaq |
| Incyte Corporation | $17.93 | 2025 | Jakafi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $15.92 | 2025 | |
| Tempus Ai, INC | $14.98 | 2025 | Xt Cdx |
| Array Biopharma INC | $14.54 | 2025 | Braftovi, Lorbrena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.